Source:http://linkedlifedata.com/resource/pubmed/id/15176317
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
Pt B
|
pubmed:dateCreated |
2004-6-4
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0065-2598
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
539
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
635-48
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:15176317-Adhesins, Escherichia coli,
pubmed-meshheading:15176317-Escherichia coli,
pubmed-meshheading:15176317-Fimbriae, Bacterial,
pubmed-meshheading:15176317-Fimbriae Proteins,
pubmed-meshheading:15176317-Humans,
pubmed-meshheading:15176317-Urinary Tract Infections,
pubmed-meshheading:15176317-Vaccines, Synthetic
|
pubmed:year |
2003
|
pubmed:articleTitle |
Development of a recombinant FimCH vaccine for urinary tract infections.
|
pubmed:affiliation |
MedImmune, Inc., Gaithersburg, MD, USA.
|
pubmed:publicationType |
Journal Article,
Review
|